351 related articles for article (PubMed ID: 19121297)
21. Intrahippocampal administration of the branched-chain alpha-hydroxy acids accumulating in maple syrup urine disease compromises rat performance in aversive and non-aversive behavioral tasks.
Vasques Vde C; Brinco F; Wajner M
J Neurol Sci; 2005 May; 232(1-2):11-21. PubMed ID: 15850577
[TBL] [Abstract][Full Text] [Related]
22. Quantification of branched-chain amino acids in blood spots and plasma by liquid chromatography tandem mass spectrometry for the diagnosis of maple syrup urine disease.
Sowell J; Pollard L; Wood T
J Sep Sci; 2011 Mar; 34(6):631-9. PubMed ID: 21328532
[TBL] [Abstract][Full Text] [Related]
23. [Experiences with a new amino acid analyzer for a rapid analysis].
Irtel von Brenndorff A; Hagge W
Monatsschr Kinderheilkd (1902); 1970 Jun; 118(6):417-9. PubMed ID: 5523694
[No Abstract] [Full Text] [Related]
24. Pathophysiology of maple syrup urine disease: Focus on the neurotoxic role of the accumulated branched-chain amino acids and branched-chain α-keto acids.
Amaral AU; Wajner M
Neurochem Int; 2022 Jul; 157():105360. PubMed ID: 35577033
[TBL] [Abstract][Full Text] [Related]
25. Prospective study of maple-syrup-urine disease for the first four days of life.
DiGeorge AM; Rezvani I; Garibaldi LR; Schwartz M
N Engl J Med; 1982 Dec; 307(24):1492-5. PubMed ID: 7144815
[No Abstract] [Full Text] [Related]
26. Stimulation of lipid peroxidation in vitro in rat brain by the metabolites accumulating in maple syrup urine disease.
Fontella FU; Gassen E; Pulrolnik V; Wannmacher CM; Klein AB; Wajner M; Dutra-Filho CS
Metab Brain Dis; 2002 Mar; 17(1):47-54. PubMed ID: 11894849
[TBL] [Abstract][Full Text] [Related]
27. L-carnitine Prevents Oxidative Stress in the Brains of Rats Subjected to a Chemically Induced Chronic Model of MSUD.
Mescka CP; Rosa AP; Schirmbeck G; da Rosa TH; Catarino F; de Souza LO; Guerreiro G; Sitta A; Vargas CR; Dutra-Filho CS
Mol Neurobiol; 2016 Nov; 53(9):6007-6017. PubMed ID: 26526843
[TBL] [Abstract][Full Text] [Related]
28. Glucose and alanine metabolism in children with maple syrup urine disease.
Haymond MW; Ben-Galim E; Strobel KE
J Clin Invest; 1978 Aug; 62(2):398-405. PubMed ID: 670400
[TBL] [Abstract][Full Text] [Related]
29. Alpha-ketoisocaproic acid and leucine provoke mitochondrial bioenergetic dysfunction in rat brain.
Amaral AU; Leipnitz G; Fernandes CG; Seminotti B; Schuck PF; Wajner M
Brain Res; 2010 Apr; 1324():75-84. PubMed ID: 20153737
[TBL] [Abstract][Full Text] [Related]
30. Tailoring of the diet for the individual in maple syrup urine disease: long-term home dietary treatment of an adult patient with MSUD by monitoring of daily intake with a personal computer. A case report.
Lie IE; Haugstad S; Holm H
Hum Nutr Appl Nutr; 1985 Apr; 39(2):130-6. PubMed ID: 3839494
[TBL] [Abstract][Full Text] [Related]
31. Combined nutritional support and continuous extracorporeal removal therapy in the severe acute phase of maple syrup urine disease.
Jouvet P; Jugie M; Rabier D; Desgrès J; Hubert P; Saudubray JM; Man NK
Intensive Care Med; 2001 Nov; 27(11):1798-806. PubMed ID: 11810125
[TBL] [Abstract][Full Text] [Related]
32. Alteration in plasma amino acid concentrations following subtotal hepatectomy in dogs.
Nagasue N; Kanashima R; Inokuchi K
Ann Chir Gynaecol; 1981; 70(2):50-5. PubMed ID: 6797341
[TBL] [Abstract][Full Text] [Related]
33. Evidence of common ancestry for the maple syrup urine disease (MSUD) Y438N allele in non-Mennonite MSUD patients.
Love-Gregory LD; Grasela J; Hillman RE; Phillips CL
Mol Genet Metab; 2002 Jan; 75(1):79-90. PubMed ID: 11825067
[TBL] [Abstract][Full Text] [Related]
34. Melatonin improves behavioral parameters and oxidative stress in zebrafish submitted to a leucine-induced MSUD protocol.
Duarte MB; Medeiros BZ; da Silva Lemos I; da Silva GL; Alano CG; Dondossola ER; Torres CA; Effting PS; Rico EP; Streck EL
Metab Brain Dis; 2023 Aug; 38(6):2105-2114. PubMed ID: 37099078
[TBL] [Abstract][Full Text] [Related]
35. Alterations in lipid peroxidation and antioxidant status in different types of intracranial tumors within their relative peritumoral tissues.
Zengin E; Atukeren P; Kokoglu E; Gumustas MK; Zengin U
Clin Neurol Neurosurg; 2009 May; 111(4):345-51. PubMed ID: 19117666
[TBL] [Abstract][Full Text] [Related]
36. [Maple syrup urine disease and cystathioninemia].
Simma B; Sperl W; Berger H
Padiatr Padol; 1989; 24(1):69-75. PubMed ID: 2497426
[TBL] [Abstract][Full Text] [Related]
37. Impact of longitudinal plasma leucine levels on the intellectual outcome in patients with classic MSUD.
Hoffmann B; Helbling C; Schadewaldt P; Wendel U
Pediatr Res; 2006 Jan; 59(1):17-20. PubMed ID: 16326996
[TBL] [Abstract][Full Text] [Related]
38. Peritoneal dialysis in maple-syrup-urine disease: studies on branched-chain amino and keto acids.
Wendel U; Becker K; Przyrembel H; Bulla M; Manegold C; Mench-Hoinowski A; Langenbeck U
Eur J Pediatr; 1980 Jun; 134(1):57-63. PubMed ID: 7408911
[No Abstract] [Full Text] [Related]
39. Diagnosis of MSUD by newborn screening allows early intervention without extraneous detoxification.
Heldt K; Schwahn B; Marquardt I; Grotzke M; Wendel U
Mol Genet Metab; 2005 Apr; 84(4):313-6. PubMed ID: 15781191
[TBL] [Abstract][Full Text] [Related]
40. A variant form of branched-chain keto aciduria.
van der Horst JL; Wadman SK
Acta Paediatr Scand; 1971 Sep; 60(5):594-9. PubMed ID: 5125167
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
